Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways

Neuroscience Letters

Volumn 594, Issue , 2015, Pages 105-110

  Shi, Xiaolei ^a   Zheng, Zhenyang ^a   Li, Jie ^b   Xiao, Zijian ^a   Qi, Weiwei ^a   Zhang, Aiwu ^a   Wu, Qi ^a   Fang, Yannan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b People's Hospital of Zengcheng   (China)

Author keywords

A ; Curcumin; Inflammation; Microglia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CD68 ANTIGEN; CURCUMIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOFLUORESCENCE; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84964307788     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.03.045     Document Type: Article

References (24)

1. Henn A., Lund S., Hedtjarn M., Schrattenholz A., Porzgen P., Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009, 26:83-94.
2. Begum A.N., Jones M.R., Lim G.P., Morihara T., Kim P., Heath D.D., Rock C.L., Pruitt M.A., Yang F., Hudspeth B., Hu S., Faull K.F., Teter B., Cole G.M., Frautschy S.A. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther. 2008, 326:196-208.
3. Lemstra A.W., Groen I.W.J., Hoozemans J.J., van Haastert E.S., Rozemuller A.J., Eikelenboom P., van Gool W.A. Microglia activation in sepsis: a case-control study. J. Neuroinflamm. 2007, 4:4.
4. Ramirez B.G., Blazquez C., Gomez D.P.T., Guzman M., de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 2005, 25:1904-1913.
5. Jin C.Y., Lee J.D., Park C., Choi Y.H., Kim G.Y. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacol. Sin. 2007, 28:1645-1651.
6. Giulian D., Baker T.J. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 1986, 6:2163-2178.
7. Kang G., Kong P.J., Yuh Y.J., Lim S.Y., Yim S.V., Chun W., Kim S.S. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J. Pharmacol. Sci. 2004, 94:325-328.
8. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
9. Caesar I., Jonson M., Nilsson K.P., Thor S., Hammarstrom P. Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS one 2012, 7:e31424.
10. Tocharus J., Jamsuwan S., Tocharus C., Changtam C., Suksamrarn A. Curcuminoid analogs inhibit nitric oxide production from LPS-activated microglial cells. J. Nat. Med. 2012, 66:400-405.
11. Wegiel J., Wang K.C., Tarnawski M., Lach B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol. 2000, 100:356-364.
12. Bisht K., Wagner K.H., Bulmer A.C. Curcumin resveratrol and flavonoids as anti-inflammatory cyto- and DNA-protective dietary compounds. Toxicology 2010, 278:88-100.
13. Jung K.K., Lee H.S., Cho J.Y., Shin W.C., Rhee M.H., Kim T.G., Kang J.H., Kim S.H., Hong S., Kang S.Y. Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sci. 2006, 79:2022-2031.
14. Serpell L.C. Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta 2000, 1502:16-30.
15. Heneka M.T., O'Banion M.K., Terwel D., Kummer M.P. Neuroinflammatory processes in Alzheimer's disease. J. Neural. Transm. 2010, 117:919-947.
16. Bartov O., Sultana R., Butterfield D.A., Atlas D. Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from Abeta(1-42) toxicity. Brain Res. 2006, 1069:198-206.
17. McGeer P.L., McGeer E.G. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 2007, 28:639-647.
18. Ito S., Sawada M., Haneda M., Ishida Y., Isobe K. Amyloid-beta peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway. Neurosci. Res. 2006, 56:294-299.
19. Hamaguchi T., Ono K., Yamada M. Review: curcumin and Alzheimer's disease. CNS Neurosci. Ther. 2010, 16:285-297.
20. Wyss-Coray T. Inflammation in Alzheimer disease: driving force bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
21. Wu X., Lu Y., Dong Y., Zhang G., Zhang Y., Xu Z., Culley D.J., Crosby G., Marcantonio E.R., Tanzi R.E., Xie Z. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-alpha, IL-6, and IL-1beta. Neurobiol. Aging 2012, 33:1364-1378.
22. Cai Z., Hussain M.D., Yan L.J. Microglia neuroinflammation and beta-amyloid protein in Alzheimer's disease. Int. J. Neurosci. 2013, 307-321.
23. Xiang Z., Haroutunian V., Ho L., Purohit D., Pasinetti G.M. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia. Dis. Markers 2006, 22:95-102.
24. Yang Z., Zhao T., Zhang J.H., Feng H. Curcumin inhibits microglia inflammation and confers neuroprotection in intracerebral hemorrhage. Immunol. Lett. 2014, 89-95.